When contemplating new biopharmaceutical development and manufacturing facility construction, there are three commonly pursued industry options, Conventional, Modular, and Podular....
Approximately 20 to 25 participants representing pharma, biotech, academia, and government will come together in July to help define the future of AI in pharmaceutical R&D...